Drug donanemab seen as turning point in dementia fight
Drug donanemab seen as turning point in dementia fight
www.bbc.com Drug donanemab seen as turning point in dementia fight
The antibody treatment donanemab slows clinical decline by around a third, a large trial confirms.
The antibody treatment donanemab slows clinical decline by around a third, a large trial confirms.
You're viewing a single thread.
5 comments
For anyone interested in neuroscience, https://kbin.social/m/neuro was just launched :)